Going both ways: Immune regulation via CD1d-dependent NKT cells
AUTOR(ES)
Godfrey, Dale I.
FONTE
American Society for Clinical Investigation
RESUMO
NKT cells are a unique T lymphocyte sublineage that has been implicated in the regulation of immune responses associated with a broad range of diseases, including autoimmunity, infectious diseases, and cancer. In stark contrast to both conventional T lymphocytes and other types of Tregs, NKT cells are reactive to the nonclassical class I antigen–presenting molecule CD1d, and they recognize glycolipid antigens rather than peptides. Moreover, they can either up- or downregulate immune responses by promoting the secretion of Th1, Th2, or immune regulatory cytokines. This review will explore the diverse influences of these cells in various disease models, their ability to suppress or enhance immunity, and the potential for manipulating these cells as a novel form of immunotherapy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=525753Documentos Relacionados
- Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
- Role of CD1d-Restricted NKT Cells in Microbial Immunity
- CD1d and invariant NKT cells at the human maternal–fetal interface
- Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells
- SURVEY AND SUMMARY: Having it both ways: transcription factors that bind DNA and RNA